格隆汇3月19日丨永胜医疗(01612.HK)发布公告,集团于截至2024年12月31日止年度录得收入增长11.6%,达801.0百万港元。来自成像一次性产品分部的收入增加37.7%至393.3百万港元,归因于与主要客户加强合作以及全球医学造影诊断服务市场增长。本年度溢利增加21.8%至70.9百万港元。净利率增加至8.9%(2023年:8.1%)。董事会已议决宣派本年度末期股息每股1.7港仙(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.